How the Pharmaceutical Industry is Tackling Scope 3 Emissions

January 4, 2022

The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions and mitigating the overall environmental impact of the pharmaceutical industry. By working with Schneider Electric and other leading pharmaceutical companies, Energize aims to assist pharmaceutical suppliers in adopting renewable energy by providing education and removing market barriers.

In this video, representatives from two pharmaceutical companies participating in this program, GSK and Novartis, talk about the goal of the program and the potential for this model to be scaled to other sectors.

Previous Article
Plastic Omnium's Carbon Neutrality Roadmap
Plastic Omnium's Carbon Neutrality Roadmap

Plastic Omnium unveils the details of its sustainability efforts and carbon neutrality roadmap, co-designed...

Next Article
BentallGreenOak commits to achieve Net Zero emissions by 2050
BentallGreenOak commits to achieve Net Zero emissions by 2050

BentallGreenOak joined the Net Zero Asset Managers initiative, committing the company to achieving Net Zero...